The conference is a prestigious international event attended by over 1,800 representatives of financial institutions, private equity, strategic investors and representatives of the life-science sector. During the conference, important partnering meetings, company presentations as well as thematic panels with the participation of world-class experts in the field of pharmacy, biotechnology, health care and management of pharmaceutical companies are held.
The Company will be represented by Artur Chabowski, President of the Management Board. The aim of the meeting is to hone investor relationships with foreign funds, the Company’s shareholders. B2B meetings with potential partners will also take place. The Company’s participation in the event is an element of the Company implementing its strategy consisting in increasing its presence and recognisability among international financial institutions.